HKD 2.27
(-1.3%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 24.42 Million HKD | -12.24% |
2022 | 27.83 Million HKD | 17.45% |
2021 | 23.69 Million HKD | 58.71% |
2020 | 14.93 Million HKD | -54.49% |
2019 | 32.8 Million HKD | -50.53% |
2018 | 66.31 Million HKD | 112.93% |
2017 | 31.14 Million HKD | -56.99% |
2016 | 72.41 Million HKD | -2.47% |
2015 | 74.24 Million HKD | 803.04% |
2014 | 8.22 Million HKD | -79.95% |
2013 | 41 Million HKD | -29.94% |
2012 | 58.53 Million HKD | 5.22% |
2011 | 55.62 Million HKD | 5.62% |
2010 | 52.66 Million HKD | 13.24% |
2009 | 46.5 Million HKD | -11.75% |
2008 | 52.7 Million HKD | 63.39% |
2007 | 32.25 Million HKD | 5.48% |
2006 | 30.58 Million HKD | -17.16% |
2005 | 36.91 Million HKD | 86.69% |
2004 | 19.77 Million HKD | -40.05% |
2003 | 32.98 Million HKD | -28.03% |
2002 | 45.83 Million HKD | -17.57% |
2001 | 55.6 Million HKD | 39.39% |
2000 | 39.89 Million HKD | -8.07% |
1999 | 43.39 Million HKD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 54.08 Million HKD | 0.0% |
2023 FY | 24.42 Million HKD | -12.24% |
2023 Q4 | 13.57 Million HKD | 0.0% |
2023 Q2 | 10.84 Million HKD | 0.0% |
2022 FY | 27.83 Million HKD | 17.45% |
2022 Q2 | 13.16 Million HKD | 0.0% |
2022 Q4 | 14.66 Million HKD | 0.0% |
2021 Q2 | 8.76 Million HKD | 0.0% |
2021 Q4 | 14.93 Million HKD | 0.0% |
2021 FY | 23.69 Million HKD | 58.71% |
2020 Q4 | 717 Thousand HKD | 0.0% |
2020 FY | 14.93 Million HKD | -54.49% |
2020 Q2 | 14.21 Million HKD | 0.0% |
2019 Q4 | 20.03 Million HKD | 0.0% |
2019 FY | 32.8 Million HKD | -50.53% |
2019 Q2 | 12.77 Million HKD | 0.0% |
2018 FY | 66.31 Million HKD | 112.93% |
2018 Q4 | 44.05 Million HKD | 0.0% |
2018 Q2 | 22.26 Million HKD | 0.0% |
2017 FY | 31.14 Million HKD | -56.99% |
2017 Q2 | 9.27 Million HKD | 0.0% |
2017 Q4 | 21.87 Million HKD | 0.0% |
2016 Q2 | 53.41 Million HKD | 0.0% |
2016 Q4 | 19 Million HKD | 0.0% |
2016 FY | 72.41 Million HKD | -2.47% |
2015 Q2 | 35.5 Million HKD | 0.0% |
2015 Q4 | 38.74 Million HKD | 0.0% |
2015 FY | 74.24 Million HKD | 803.04% |
2014 Q4 | 11.27 Million HKD | 0.0% |
2014 FY | 8.22 Million HKD | -79.95% |
2014 Q2 | 3.05 Million HKD | 0.0% |
2013 FY | 41 Million HKD | -29.94% |
2013 Q4 | 16.17 Million HKD | 0.0% |
2013 Q2 | 24.83 Million HKD | 0.0% |
2012 Q1 | 14.63 Million HKD | 0.0% |
2012 FY | 58.53 Million HKD | 5.22% |
2012 Q2 | 14.63 Million HKD | 0.0% |
2012 Q4 | 16.26 Million HKD | 11.18% |
2012 Q3 | 14.63 Million HKD | 0.0% |
2011 Q2 | 13.9 Million HKD | 0.0% |
2011 Q4 | 14.63 Million HKD | 5.22% |
2011 Q3 | 13.9 Million HKD | 0.0% |
2011 Q1 | 13.9 Million HKD | 0.0% |
2011 FY | 55.62 Million HKD | 5.62% |
2010 Q3 | 13.16 Million HKD | 0.0% |
2010 Q2 | 13.16 Million HKD | 0.0% |
2010 Q4 | 13.9 Million HKD | 5.62% |
2010 FY | 52.66 Million HKD | 13.24% |
2010 Q1 | 13.16 Million HKD | 0.0% |
2009 Q4 | 13.16 Million HKD | 13.24% |
2009 FY | 46.5 Million HKD | -11.75% |
2009 Q1 | 11.62 Million HKD | 0.0% |
2009 Q2 | 11.62 Million HKD | 0.0% |
2009 Q3 | 11.62 Million HKD | 0.0% |
2008 Q2 | 13.17 Million HKD | 0.0% |
2008 Q3 | 13.17 Million HKD | 0.0% |
2008 Q4 | 11.62 Million HKD | -11.75% |
2008 FY | 52.7 Million HKD | 63.39% |
2008 Q1 | 13.17 Million HKD | 0.0% |
2007 Q3 | 8.06 Million HKD | 0.0% |
2007 Q1 | 8.06 Million HKD | 0.0% |
2007 FY | 32.25 Million HKD | 5.48% |
2007 Q2 | 8.06 Million HKD | 0.0% |
2007 Q4 | 13.17 Million HKD | 63.39% |
2006 Q3 | 7.64 Million HKD | 0.0% |
2006 Q1 | 7.64 Million HKD | 0.0% |
2006 Q2 | 7.64 Million HKD | 0.0% |
2006 Q4 | 8.06 Million HKD | 5.48% |
2006 FY | 30.58 Million HKD | -17.16% |
2005 Q4 | 7.64 Million HKD | -17.16% |
2005 FY | 36.91 Million HKD | 86.69% |
2005 Q3 | 9.22 Million HKD | 0.0% |
2005 Q2 | 9.22 Million HKD | 0.0% |
2005 Q1 | 9.22 Million HKD | 0.0% |
2004 Q1 | 4.94 Million HKD | 0.0% |
2004 FY | 19.77 Million HKD | -40.05% |
2004 Q4 | 9.22 Million HKD | 86.69% |
2004 Q3 | 4.94 Million HKD | 0.0% |
2004 Q2 | 4.94 Million HKD | 0.0% |
2003 Q4 | 4.94 Million HKD | -40.05% |
2003 FY | 32.98 Million HKD | -28.03% |
2003 Q1 | 8.24 Million HKD | 0.0% |
2003 Q2 | 8.24 Million HKD | 0.0% |
2003 Q3 | 8.24 Million HKD | 0.0% |
2002 Q3 | 11.45 Million HKD | 0.0% |
2002 Q4 | 8.24 Million HKD | -28.03% |
2002 Q2 | 11.45 Million HKD | 0.0% |
2002 Q1 | 11.45 Million HKD | 0.0% |
2002 FY | 45.83 Million HKD | -17.57% |
2001 Q4 | 11.45 Million HKD | -17.57% |
2001 Q3 | 13.9 Million HKD | 0.0% |
2001 Q2 | 13.9 Million HKD | 0.0% |
2001 FY | 55.6 Million HKD | 39.39% |
2001 Q1 | 13.9 Million HKD | 0.0% |
2000 Q1 | 9.97 Million HKD | 0.0% |
2000 Q4 | 13.9 Million HKD | 39.39% |
2000 Q3 | 9.97 Million HKD | 0.0% |
2000 Q2 | 9.97 Million HKD | 0.0% |
2000 FY | 39.89 Million HKD | -8.07% |
1999 FY | 43.39 Million HKD | 0.0% |
1999 Q2 | 10.84 Million HKD | 0.0% |
1999 Q1 | 10.84 Million HKD | 0.0% |
1999 Q4 | 9.97 Million HKD | -8.07% |
1999 Q3 | 10.84 Million HKD | 0.0% |
1998 Q4 | 10.84 Million HKD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 99.367% |
Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | 31.252% |
Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | 93.099% |
Qianhai Health Holdings Limited | 17.1 Million HKD | -42.814% |
Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | 95.867% |
Essex Bio-Technology Limited | 1.22 Billion HKD | 98.013% |
Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | 95.149% |
PuraPharm Corporation Limited | 216.62 Million HKD | 88.725% |
SSY Group Limited | 1.98 Billion HKD | 98.767% |
JBM (Healthcare) Limited | 163.87 Million HKD | 85.096% |
Jacobson Pharma Corporation Limited | 287.34 Million HKD | 91.5% |
China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 99.917% |